Patients with vs without keloids had a higher prevalence of interstitial lung disease after controlling for patient specific factors.
A panel of experts, including Dr Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung ...
Patients with vs without rheumatoid arthritis (RA), especially those with RA-associated interstitial lung disease (RA-ILD), have a significantly higher risk of developing lung cancer, according to ...
The following is a summary of “Evaluating sensitization-associated, neuropathic-like symptoms and psychological factors in ...
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...
Diffuse (interstitial) lung disease includes a wide variety of relatively uncommon conditions presenting with characteristic clusters of clinical features and marked by an immune response.
National Youth Tobacco Survey e-cigarette and nicotine pouch data from the U.S. Food and Drug Administration (FDA) and the ...
Merck reported topline data from its HERTHENA-Lung02 phase 3 trial of patritumab deruxtecan in EGFR-mutated non-small cell ...
Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic ...
The Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.
The American Lung Association in Virginia announced the start of its 2025-2026 research awards and grants cycle at the end of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback